Disease risk: Difference between revisions
(→Calculations: ovariable InpBoD defined and BoDt replaced) |
|||
Line 166: | Line 166: | ||
"65 to 69","70 to 74","75 to 79","80 plus")] <- ">45" | "65 to 69","70 to 74","75 to 79","80 plus")] <- ">45" | ||
levels(dat$Cause)[levels(dat$Cause)== "All causes"] <- " | levels(dat$Cause)[levels(dat$Cause)== "All causes"] <- "All-cause mortality" | ||
#levels(dat$Cause)[levels(dat$Cause)== "Breast cancer"] | #levels(dat$Cause)[levels(dat$Cause)== "Breast cancer"] | ||
levels(dat$Cause)[levels(dat$Cause)== "Caries of permanent teeth"] <- "Yes or no dental defect" | levels(dat$Cause)[levels(dat$Cause)== "Caries of permanent teeth"] <- "Yes or no dental defect" |
Revision as of 20:24, 8 September 2019
Moderator:Nobody (see all) Click here to sign up. |
This page is a stub. You may improve it into a full page. |
Upload data
|
Question
What are incidence or prevalence rates of different diseases in Finland?
Answer
----#: . Code seems to work, but gives out the yellow errorbox. --Heta 13:02, 27 August 2013 (EEST) (type: truth; paradigms: science: comment)
Rationale
Data
- Burden of disease as DALY in Finland ⇤--#: . Inactivate and merge? --Jouni (talk) 16:03, 13 April 2017 (UTC) (type: truth; paradigms: science: attack)
Data from op_fi:Seturi/tautiriski
Population column defines the relevant population subgroup other than age and sex subgroups, which are defined in their respective columns. The numbers of cases are divided by the size of the population (total population even in cases where the cases are from a subgroup only. The population size is estimated at 5375276 in 2010, and this is used as denominator in the incidence calculation.
Obs | Response | Population | Age | Sex | Unit | Incidence | Actual cases | Description |
---|---|---|---|---|---|---|---|---|
1 | Lung cancer morbidity | Whole population | cases /100000py | 42.342 | 2276 | Year 2010 cancer register | ||
2 | Cardiopulmonary mortality | Whole population | cases /100000py | 443.512 | 23840 | |||
3 | Total mortality | Whole population | cases /100000py | 940.752 | 50568 | 2011 data, Tilastokeskus | ||
4 | Bladder cancer morbidity | Whole population | cases /100000py | 16.706 | 898 | Year 2010 cancer register | ||
5 | Myocardial infarction morbidity | Whole population | cases /100000py | 463.195 | 24898 | |||
6 | Ischaemic heart disease mortality | Whole population | cases /100000py | 221.142 | 11887 | |||
7 | Coronary heart disease mortality | Whole population | cases /100000py | 221.142 | 11887 | This is a duplicate of the previous row to match more ERFs | ||
8 | CHD arrythmia mortality | Whole population | cases /100000py | 221.142 | 11887 | This is a duplicate of the previous row to match more ERFs | ||
9 | Asthma morbidity | Whole population | cases /100000py | 270.888 | 14561 | |||
10 | Asthma morbidity | Whole population | >21 | cases /100000py | 176.103 | 9466 | ||
11 | Asthma morbidity | Whole population | <14 | cases /100000py | 81.224 | 4366 | ||
12 | Pulmonary infection morbidity | Whole population | <2 | DALY | 35 | |||
13 | Otitis media | Whole population | <3 | DALY | 48 | |||
14 | Lower respiratory symptoms morbidity | Whole population | cases /100000py | 8985.585 | 483000 | |||
15 | Upper respiratory symptoms morbidity | Whole population | cases /100000py | 17279.969 | 928846 | |||
16 | Ischaemic heart disease/myocardial infarction morbidity | Whole population | 35-64 | Male | cases /100000py | 86.6 | 4655 | 35-64v miesten 1. infarktin insidenssi 354/100000 1991-4. Aromaa ym Suomalaisten terveys s155 |
17 | CHD | Whole population | 35-64 | Male | cases /100000py | 86.6 | 4655 | 35-64v miesten 1. infarktin insidenssi 354/100000 1991-4. Aromaa ym Suomalaisten terveys s155. This is a duplicate of the previous row to match more ERFs |
18 | Nasal cancer morbidity | Whole population | 20-64 | cases /100000py | 0.651 | 35 | Age boundaries are assumed without original data | |
19 | COPD mortality | Whole population | 15-64 | cases /100000py | 20.966 | 1127 | ||
20 | Asthma morbidity2 | Whole population | 15-64 | Male | cases /100000py | 58.044 | 3120 | |
21 | Asthma morbidity2 | Whole population | 15-64 | Female | cases /100000py | 78.954 | 4244 | |
22 | Cancer morbidity | Whole population | cases /100000py | 202.408 | 10880 | |||
23 | Cancer lifetime probability | Whole population | probability | 1 | This is used with absolute risk functions such as CSF to get rid of the parameter relative to background | |||
24 | All skin cancers and basalioma morbidity | Whole population | cases /100000py | 163.285 | 8777 | |||
25 | Skin cancer morbidity | Whole population | cases /100000py | 37.3 | 2005 | |||
26 | Melanoma morbidity | Whole population | cases /100000py | 16.855 | 906 | |||
27 | Carcinoma spinocellulare morbidity | Whole population | cases /100000py | 20.445 | 1099 | |||
28 | Basalioma morbidity | Whole population | cases /100000py | 125.984 | 6772 | |||
29 | Leukemia morbidity | Whole population | cases /100000py | 10.027 | 539 | Year 2010, cancer register |
DALY/a thousands WHO 2002 EU-27 OECD, 22 Population, millions Trachea, bronchus & lung cancers Cardio-vascular diseases Trachea, bronchus & lung cancers Cardio-vascular diseases
Obs | Country | EU-27 | OECD22 | Population | Trachea bronchus & lung cancers DALY/a thousands | Cardio-vascular diseases DALY/a thousands | Trachea bronchus & lung cancers DALY/a/100 000 | Cardio-vascular diseases DALY/a/100 000 | (sub)urban 2009-11 PM2.5 mean μg/m3 | Description |
---|---|---|---|---|---|---|---|---|---|---|
1 | Austria | 1 | 1 | 8.4 | 27 | 189 | 321 | 2244 | 18.9 | |
2 | Belgium | 1 | 1 | 11.0 | 55 | 209 | 499 | 1898 | 17.6 | |
3 | Bulgaria | 1 | 0 | 7.3 | 32 | 526 | 435 | 7157 | 31.4 | |
4 | Cyprus | 1 | 0 | 0.9 | 1 | 21 | 117 | 2467 | 21.3 | |
5 | Czech Republic | 1 | 1 | 10.5 | 52 | 352 | 495 | 3352 | 23.0 | |
6 | Denmark | 1 | 1 | 5.6 | 26 | 114 | 461 | 2021 | 14.0 | |
7 | Estonia | 1 | 0 | 1.3 | 5 | 65 | 373 | 4852 | 19.5 | |
8 | Finland | 1 | 1 | 5.4 | 14 | 122 | 260 | 2266 | 7.3 | |
9 | France | 1 | 1 | 65.2 | 243 | 857 | 373 | 1315 | 17.9 | |
10 | Germany | 1 | 1 | 81.8 | 354 | 2070 | 433 | 2530 | 16.8 | |
11 | Greece | 1 | 1 | 10.8 | 49 | 341 | 453 | 3153 | 19.4 | |
12 | Hungary | 1 | 1 | 10.0 | 76 | 410 | 762 | 4113 | 22.6 | |
13 | Ireland | 1 | 1 | 4.5 | 12 | 77 | 265 | 1703 | 10.8 | |
14 | Italy | 1 | 1 | 60.7 | 238 | 1222 | 392 | 2013 | 21.5 | |
15 | Latvia | 1 | 0 | 2.1 | 10 | 130 | 486 | 6318 | 15.1 | |
16 | Lithuania | 1 | 0 | 3.0 | 13 | 138 | 429 | 4555 | 12.7 | |
17 | Luxembourg | 1 | 1 | 0.5 | 2 | 9 | 381 | 1715 | 15.9 | |
18 | Malta | 1 | 0 | 0.4 | 1 | 8 | 240 | 1920 | 13.6 | |
19 | Netherlands | 1 | 1 | 16.7 | 73 | 307 | 437 | 1839 | 17.0 | |
20 | Norway | 0 | 1 | 5.0 | 15 | 87 | 303 | 1756 | ||
21 | Poland | 1 | 1 | 38.5 | 215 | 1226 | 558 | 3181 | 28.2 | |
22 | Portugal | 1 | 1 | 10.6 | 29 | 263 | 275 | 2491 | 8.6 | |
23 | Romania | 1 | 0 | 21.4 | 92 | 1094 | 430 | 5118 | 18.1 | |
24 | Slovakia | 1 | 1 | 5.4 | 19 | 175 | 352 | 3242 | 25.0 | |
25 | Slovenia | 1 | 0 | 2.1 | 9 | 51 | 439 | 2485 | 21.5 | |
26 | Spain | 1 | 1 | 46.2 | 155 | 670 | 336 | 1450 | 12.5 | |
27 | Sweden | 1 | 1 | 9.4 | 23 | 187 | 244 | 1981 | 8.0 | |
28 | Switzerland | 0 | 1 | 7.9 | 25 | 116 | 316 | 1465 | ||
29 | Turkey | 0 | 1 | 74.8 | 115 | 2082 | 154 | 2785 | ||
30 | United Kingdom | 1 | 1 | 62.8 | 230 | 1297 | 366 | 2065 | 13.3 | |
31 | All of the above | 590.2 | 2210 | 14415 | 374 | 2442 | 17.7 | |||
32 | EU27 Total | 502.6 | 2055 | 12130 | 409 | 2413 | 17.7 | |||
33 | OECD Europe total | 553.1 | 2052 | 12447 | 371 | 2250 | 17.7 |
Calculations
InpBoD is an ovariable to calculate total burden of disease for selected endpoints based on IHME data.
See also
- OECD health data [1]
Keywords
References
Related files
<mfanonymousfilelist></mfanonymousfilelist>